Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1873
9.740
 Why?
Anti-Asthmatic Agents
28
2025
264
3.410
 Why?
Adrenal Cortex Hormones
28
2025
488
3.390
 Why?
Forced Expiratory Volume
19
2019
474
1.570
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
1027
1.380
 Why?
Severity of Illness Index
20
2020
2809
0.990
 Why?
Administration, Inhalation
25
2025
582
0.970
 Why?
Anti-Inflammatory Agents
10
2016
463
0.890
 Why?
Albuterol
5
2015
74
0.850
 Why?
Bronchodilator Agents
12
2016
194
0.840
 Why?
Lung Transplantation
10
2017
312
0.840
 Why?
Budesonide
14
2016
56
0.810
 Why?
Remote Consultation
4
2025
53
0.770
 Why?
Nedocromil
11
2016
23
0.730
 Why?
Humans
129
2025
136965
0.720
 Why?
Nasal Polyps
1
2021
59
0.700
 Why?
Self Report
3
2023
836
0.700
 Why?
Endpoint Determination
2
2020
75
0.680
 Why?
Pharmacogenetics
2
2015
165
0.680
 Why?
Food Hypersensitivity
1
2022
182
0.620
 Why?
Sinusitis
1
2021
221
0.610
 Why?
Virus Diseases
1
2021
212
0.590
 Why?
Lung
7
2019
4035
0.590
 Why?
Glucocorticoids
4
2022
519
0.580
 Why?
Physicians
2
2021
921
0.570
 Why?
Hospitalization
13
2020
2182
0.560
 Why?
Symptom Assessment
1
2019
128
0.560
 Why?
Sleep Apnea, Obstructive
1
2021
303
0.530
 Why?
Androstadienes
3
2012
77
0.520
 Why?
Oxygen Inhalation Therapy
4
2020
160
0.510
 Why?
Child
53
2022
21760
0.510
 Why?
Disease Progression
14
2020
2708
0.510
 Why?
Bone Density
2
2014
488
0.510
 Why?
Male
82
2025
67386
0.490
 Why?
Managed Care Programs
8
2008
141
0.490
 Why?
Emergency Service, Hospital
9
2013
2080
0.490
 Why?
Adult
47
2025
37715
0.480
 Why?
Precision Medicine
1
2020
415
0.480
 Why?
Female
81
2025
73002
0.460
 Why?
Patient Reported Outcome Measures
1
2018
399
0.450
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
27
0.450
 Why?
Cost Savings
1
2015
84
0.450
 Why?
Practice Patterns, Physicians'
7
2020
1295
0.440
 Why?
Middle Aged
40
2025
33226
0.410
 Why?
Cost-Benefit Analysis
7
2022
578
0.410
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.410
 Why?
Phenotype
6
2025
3148
0.390
 Why?
Comorbidity
4
2021
1626
0.370
 Why?
Academic Medical Centers
3
2024
504
0.360
 Why?
Surveys and Questionnaires
14
2022
5812
0.350
 Why?
Adolescent
37
2019
21471
0.350
 Why?
Administration, Oral
6
2021
783
0.340
 Why?
Medical Records Systems, Computerized
3
2008
99
0.340
 Why?
Quality of Life
12
2023
2899
0.340
 Why?
Mentors
1
2012
209
0.330
 Why?
Respiratory Function Tests
10
2015
559
0.320
 Why?
United States
23
2022
14945
0.320
 Why?
Child, Preschool
31
2016
10952
0.310
 Why?
Treatment Outcome
16
2025
10664
0.310
 Why?
Faculty, Medical
1
2012
287
0.310
 Why?
Interprofessional Relations
3
2021
285
0.310
 Why?
Child Development
1
2014
466
0.310
 Why?
Spirometry
8
2020
260
0.300
 Why?
Group Practice
1
2008
7
0.290
 Why?
Oxygen
3
2018
946
0.290
 Why?
Anti-Allergic Agents
2
2008
41
0.290
 Why?
Aged
22
2022
23803
0.280
 Why?
Computer Simulation
1
2012
982
0.280
 Why?
Dyspnea
3
2022
250
0.260
 Why?
Drug Utilization
4
2005
169
0.250
 Why?
Follow-Up Studies
17
2017
5048
0.250
 Why?
Primary Health Care
5
2025
1775
0.250
 Why?
Primary Graft Dysfunction
2
2017
32
0.250
 Why?
Quality Assurance, Health Care
1
2008
324
0.240
 Why?
Bronchiolitis Obliterans
3
2017
68
0.240
 Why?
Respiratory Sounds
1
2006
109
0.240
 Why?
Gift Giving
1
2005
12
0.240
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.240
 Why?
Allergists
2
2022
11
0.230
 Why?
Genetic Testing
1
2008
455
0.230
 Why?
Randomized Controlled Trials as Topic
7
2020
1460
0.230
 Why?
Delivery of Health Care
2
2021
957
0.220
 Why?
Retrospective Studies
18
2024
15536
0.220
 Why?
Medication Adherence
2
2023
489
0.220
 Why?
Cohort Studies
14
2013
5688
0.220
 Why?
Specialization
2
2025
147
0.210
 Why?
Time Factors
10
2020
6786
0.210
 Why?
Natural Language Processing
1
2025
96
0.210
 Why?
Antibodies, Monoclonal
2
2008
1412
0.210
 Why?
Leadership
2
2022
393
0.210
 Why?
Massachusetts
5
2016
172
0.210
 Why?
Medicine
1
2025
124
0.200
 Why?
Rhinitis, Allergic, Perennial
1
2003
21
0.200
 Why?
Genetic Variation
1
2008
1000
0.200
 Why?
Recurrence
5
2013
1059
0.200
 Why?
Steroids
8
2011
157
0.200
 Why?
Genetic Predisposition to Disease
2
2025
2371
0.200
 Why?
Health Status
1
2008
817
0.190
 Why?
Predictive Value of Tests
9
2012
1999
0.190
 Why?
Multicenter Studies as Topic
4
2018
305
0.190
 Why?
Young Adult
11
2019
13218
0.190
 Why?
Beclomethasone
1
2022
9
0.190
 Why?
Prevalence
4
2022
2732
0.190
 Why?
Models, Theoretical
4
2007
581
0.180
 Why?
Tiotropium Bromide
2
2018
5
0.180
 Why?
Desensitization, Immunologic
1
2022
95
0.180
 Why?
Nebulizers and Vaporizers
2
2020
64
0.180
 Why?
Biomarkers
3
2021
4095
0.180
 Why?
Patient Preference
1
2023
197
0.170
 Why?
Social Class
2
2022
282
0.170
 Why?
Churg-Strauss Syndrome
1
2020
26
0.170
 Why?
Bronchoconstriction
3
2011
29
0.170
 Why?
Pulmonologists
1
2020
14
0.170
 Why?
Granulomatosis with Polyangiitis
1
2020
45
0.170
 Why?
Capacity Building
1
2021
61
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
34
0.160
 Why?
Electronic Health Records
2
2025
1087
0.160
 Why?
Physician-Patient Relations
2
2021
577
0.160
 Why?
Practice Guidelines as Topic
5
2020
1543
0.160
 Why?
Risk Factors
12
2018
10363
0.160
 Why?
Air Pollution, Indoor
2
2002
179
0.150
 Why?
Treatment Adherence and Compliance
1
2019
26
0.150
 Why?
Exercise Test
1
2022
617
0.150
 Why?
Receptors, IgE
2
2009
44
0.150
 Why?
Prognosis
8
2017
3931
0.140
 Why?
Allergens
1
2021
394
0.140
 Why?
Vitamin D
2
2012
396
0.140
 Why?
Fossil Fuels
1
1997
10
0.140
 Why?
Emergency Medical Services
2
2007
556
0.140
 Why?
Hypersensitivity
1
2020
249
0.140
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Biological Products
1
2020
217
0.130
 Why?
Drug Prescriptions
2
2011
258
0.130
 Why?
Respiration
1
2017
203
0.130
 Why?
Respiration Disorders
1
1997
76
0.130
 Why?
Physicians, Primary Care
3
2021
225
0.130
 Why?
Drug Combinations
3
2012
341
0.130
 Why?
Statistics, Nonparametric
1
2017
420
0.120
 Why?
Aged, 80 and over
6
2019
7559
0.120
 Why?
Drug Therapy, Combination
5
2020
1022
0.120
 Why?
Immunomodulation
1
2017
98
0.120
 Why?
Breath Tests
2
2008
74
0.120
 Why?
Socioeconomic Factors
4
2022
1310
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Patient Admission
1
2018
197
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Tobacco Smoke Pollution
2
2010
258
0.120
 Why?
Immunoglobulin G
1
2020
892
0.120
 Why?
Cholinergic Antagonists
1
2015
23
0.120
 Why?
Transplants
1
2015
37
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
100
0.120
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
8
0.120
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.120
 Why?
Referral and Consultation
1
2021
779
0.110
 Why?
Genomics
2
2018
804
0.110
 Why?
Longitudinal Studies
6
2017
2851
0.110
 Why?
Postoperative Complications
2
2017
2622
0.110
 Why?
Overweight
2
2011
576
0.110
 Why?
Respiratory Tract Infections
2
2012
384
0.110
 Why?
Telemedicine
1
2023
863
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.110
 Why?
Graft Rejection
2
2013
571
0.110
 Why?
Prednisolone
1
2014
67
0.110
 Why?
Guideline Adherence
3
2020
550
0.100
 Why?
Risk
4
2015
901
0.100
 Why?
Education, Medical, Continuing
2
2005
127
0.100
 Why?
Airway Obstruction
1
2015
156
0.100
 Why?
Environmental Exposure
3
2006
573
0.100
 Why?
Quality Improvement
1
2022
1178
0.100
 Why?
Forecasting
1
2015
386
0.100
 Why?
Bronchial Hyperreactivity
3
2010
103
0.100
 Why?
Transplantation
1
2013
35
0.100
 Why?
Office Visits
4
2011
96
0.100
 Why?
Insurance Claim Review
1
2013
68
0.100
 Why?
Peer Group
2
2012
244
0.100
 Why?
Medicare
2
2022
785
0.100
 Why?
Double-Blind Method
5
2010
1904
0.100
 Why?
Growth
1
2012
53
0.100
 Why?
Research
1
2015
447
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
798
0.090
 Why?
Costs and Cost Analysis
1
2013
208
0.090
 Why?
Methacholine Chloride
3
2008
48
0.090
 Why?
Cytomegalovirus Infections
2
2012
191
0.090
 Why?
Cost of Illness
3
2003
303
0.090
 Why?
Metered Dose Inhalers
1
2012
12
0.090
 Why?
Feedback
1
2012
173
0.090
 Why?
Drug Dosage Calculations
1
2011
22
0.090
 Why?
Mycoses
1
2012
80
0.090
 Why?
Logistic Models
5
2017
2066
0.090
 Why?
Antifungal Agents
1
2012
132
0.090
 Why?
Body Height
1
2012
195
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
10
0.090
 Why?
Multivariate Analysis
7
2017
1484
0.090
 Why?
Professional Role
1
2012
166
0.090
 Why?
Medication Errors
1
2012
95
0.090
 Why?
Morbidity
2
2022
319
0.090
 Why?
Mycobacterium
1
2012
110
0.090
 Why?
Epidemiologic Studies
1
2011
71
0.090
 Why?
Obesity
3
2015
3023
0.080
 Why?
Diagnostic Errors
1
2012
171
0.080
 Why?
Patient Readmission
1
2016
699
0.080
 Why?
Pneumococcal Vaccines
1
2012
134
0.080
 Why?
Secondary Prevention
1
2012
234
0.080
 Why?
Drug Resistance
1
2011
145
0.080
 Why?
Program Development
1
2012
367
0.080
 Why?
Lung Diseases
1
2017
767
0.080
 Why?
Probability
1
2011
306
0.080
 Why?
Vitamin D Deficiency
1
2012
185
0.080
 Why?
Chi-Square Distribution
2
2017
521
0.080
 Why?
Bronchial Provocation Tests
2
2008
48
0.080
 Why?
Fluticasone
2
2008
56
0.080
 Why?
Decision Support Techniques
2
2012
420
0.080
 Why?
Incidence
5
2020
2793
0.080
 Why?
Ambulatory Care
2
2011
567
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
28
0.080
 Why?
Immunoglobulin E
2
2008
323
0.080
 Why?
Vital Capacity
4
2017
299
0.080
 Why?
Algorithms
1
2017
1700
0.080
 Why?
Lectins, C-Type
1
2009
64
0.080
 Why?
Proportional Hazards Models
1
2012
1251
0.080
 Why?
Health Services
2
2007
105
0.080
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1365
0.070
 Why?
Medication Therapy Management
1
2010
75
0.070
 Why?
Surgical Wound Infection
1
2012
304
0.070
 Why?
Odds Ratio
4
2017
1071
0.070
 Why?
Kaplan-Meier Estimate
3
2016
868
0.070
 Why?
Cross-Sectional Studies
6
2010
5530
0.070
 Why?
Pandemics
3
2022
1630
0.070
 Why?
Acute Disease
1
2011
993
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.070
 Why?
Smoking
3
2017
1609
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Mixed Function Oxygenases
1
2008
46
0.070
 Why?
Program Evaluation
1
2012
907
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
48
0.070
 Why?
Adrenergic beta-Agonists
1
2008
96
0.070
 Why?
Genetic Techniques
1
2008
67
0.070
 Why?
Quality-Adjusted Life Years
2
2006
106
0.070
 Why?
Trastuzumab
1
2008
96
0.070
 Why?
Markov Chains
2
2006
124
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
23
0.070
 Why?
Cost Sharing
1
2008
17
0.070
 Why?
State Health Plans
1
2008
31
0.070
 Why?
Smoking Cessation
1
2012
437
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
50
0.070
 Why?
Reimbursement Mechanisms
1
2008
85
0.070
 Why?
Interviews as Topic
1
2011
801
0.070
 Why?
Chronic Disease
3
2017
1774
0.070
 Why?
Omalizumab
1
2007
39
0.070
 Why?
Exercise Tolerance
2
2022
279
0.070
 Why?
Warfarin
1
2008
154
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
363
0.070
 Why?
Factor Analysis, Statistical
1
2008
290
0.070
 Why?
Health Surveys
2
2006
523
0.070
 Why?
Health Services Accessibility
2
2021
994
0.070
 Why?
Tomography, X-Ray Computed
1
2017
2654
0.060
 Why?
Databases, Factual
1
2012
1367
0.060
 Why?
Influenza Vaccines
1
2012
531
0.060
 Why?
Antiviral Agents
1
2012
757
0.060
 Why?
Animals, Domestic
1
2006
15
0.060
 Why?
Lung Diseases, Interstitial
1
2013
641
0.060
 Why?
Animals
2
2025
36882
0.060
 Why?
Receptor, ErbB-2
1
2008
341
0.060
 Why?
Eosinophils
1
2008
317
0.060
 Why?
Physicians, Family
2
2004
194
0.060
 Why?
Biomedical Research
1
2012
700
0.060
 Why?
Health Benefit Plans, Employee
1
2005
25
0.060
 Why?
Database Management Systems
1
2005
51
0.060
 Why?
Models, Biological
1
2012
1780
0.060
 Why?
Hip Fractures
1
2006
85
0.060
 Why?
Health Policy
1
2008
396
0.060
 Why?
Patients
1
2006
177
0.060
 Why?
Insurance Coverage
1
2006
231
0.060
 Why?
Infant
3
2008
9392
0.060
 Why?
Patient Education as Topic
3
2005
767
0.050
 Why?
Utilization Review
1
2004
38
0.050
 Why?
Body Mass Index
3
2015
2416
0.050
 Why?
Clinical Competence
1
2012
1114
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
604
0.050
 Why?
Gene Expression Profiling
1
2011
1747
0.050
 Why?
Medicaid
1
2008
437
0.050
 Why?
Anticoagulants
1
2008
652
0.050
 Why?
Mass Screening
1
2012
1295
0.050
 Why?
Nitric Oxide
1
2008
883
0.050
 Why?
Sex Factors
3
2016
2060
0.050
 Why?
Vaccination
1
2012
1428
0.050
 Why?
Anti-Bacterial Agents
2
2004
1784
0.050
 Why?
Attitude to Health
1
2006
452
0.050
 Why?
Clinical Trials as Topic
2
2005
1019
0.050
 Why?
Case Management
1
2003
66
0.050
 Why?
Puerto Rico
1
2022
53
0.050
 Why?
Choice Behavior
1
2004
172
0.050
 Why?
Parents
3
2006
1412
0.050
 Why?
Symptom Flare Up
1
2022
37
0.050
 Why?
Circadian Rhythm
1
2006
474
0.050
 Why?
Sputum
1
2004
304
0.050
 Why?
Academies and Institutes
1
2022
55
0.050
 Why?
Health Services Research
1
2004
406
0.040
 Why?
Lung Neoplasms
1
2015
2552
0.040
 Why?
Minority Groups
1
2003
272
0.040
 Why?
Survival Rate
2
2016
1882
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
70
0.040
 Why?
Electronics
1
2021
71
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
97
0.040
 Why?
Sample Size
1
2020
124
0.040
 Why?
Efficiency
1
2021
99
0.040
 Why?
Health Care Reform
1
2021
106
0.040
 Why?
Pragmatic Clinical Trials as Topic
1
2020
66
0.040
 Why?
Schools, Medical
1
2021
149
0.040
 Why?
Risk Assessment
3
2020
3446
0.040
 Why?
Patient Selection
2
2020
685
0.040
 Why?
Patient Compliance
2
2016
591
0.040
 Why?
Language
1
2022
300
0.040
 Why?
Stress, Psychological
1
2007
1114
0.040
 Why?
Time
1
2019
86
0.040
 Why?
Cluster Analysis
2
2014
513
0.040
 Why?
Health Education
1
2002
357
0.040
 Why?
Quality of Health Care
1
2003
648
0.040
 Why?
Poland
1
2017
35
0.040
 Why?
Republic of Korea
1
2017
38
0.030
 Why?
Bronchitis, Chronic
1
2017
25
0.030
 Why?
Cooperative Behavior
1
2021
456
0.030
 Why?
Sensitivity and Specificity
3
2013
1923
0.030
 Why?
Patient-Centered Care
1
2003
540
0.030
 Why?
Nitrogen Dioxide
1
1997
47
0.030
 Why?
Geography
1
2018
202
0.030
 Why?
Aftercare
1
2019
208
0.030
 Why?
Long-Term Care
1
2018
105
0.030
 Why?
Monitoring, Physiologic
2
2012
266
0.030
 Why?
Pediatrics
1
2005
1061
0.030
 Why?
Self Concept
1
2019
253
0.030
 Why?
Antineoplastic Agents
1
2008
2111
0.030
 Why?
Netherlands
1
2016
86
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
141
0.030
 Why?
Perception
1
2019
365
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
12
0.030
 Why?
Salmeterol Xinafoate
1
2015
22
0.030
 Why?
Ethanolamines
1
2015
14
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
33
0.030
 Why?
Feasibility Studies
1
2020
965
0.030
 Why?
Treatment Failure
1
2016
338
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2015
0.030
 Why?
Postoperative Period
1
2016
338
0.030
 Why?
Self Efficacy
1
2019
401
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2142
0.030
 Why?
Education
1
2015
110
0.030
 Why?
Age Factors
3
2008
3258
0.030
 Why?
Fatal Outcome
1
2015
302
0.030
 Why?
Immunosuppressive Agents
2
2015
861
0.030
 Why?
Biopsy
2
2013
1083
0.030
 Why?
Pilot Projects
1
2020
1730
0.030
 Why?
Patient Acceptance of Health Care
1
2021
843
0.030
 Why?
Combined Modality Therapy
1
2017
1215
0.030
 Why?
Gene Expression
1
2018
1480
0.030
 Why?
Telephone
2
2005
179
0.020
 Why?
Echinocandins
1
2012
7
0.020
 Why?
Lipopeptides
1
2012
14
0.020
 Why?
Aspergillosis
1
2012
21
0.020
 Why?
Amphotericin B
1
2012
32
0.020
 Why?
Intention to Treat Analysis
1
2012
74
0.020
 Why?
Candidiasis
1
2012
55
0.020
 Why?
Tissue Donors
1
2015
412
0.020
 Why?
Transplantation, Homologous
1
2013
409
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
298
0.020
 Why?
Hypoxia
1
2019
1108
0.020
 Why?
Mycobacterium avium Complex
1
2012
88
0.020
 Why?
Age Distribution
2
2003
388
0.020
 Why?
Cromolyn Sodium
2
2001
5
0.020
 Why?
Triazoles
1
2012
150
0.020
 Why?
Leukotriene Antagonists
1
2011
22
0.020
 Why?
Self Care
2
2005
385
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
797
0.020
 Why?
Colorado
1
2021
4542
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Principal Component Analysis
1
2011
192
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
205
0.020
 Why?
Genome-Wide Association Study
1
2016
1395
0.020
 Why?
Health
1
2010
83
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Environment
1
2011
339
0.020
 Why?
Observation
1
2008
50
0.020
 Why?
Sex Ratio
1
2008
15
0.020
 Why?
Least-Squares Analysis
1
2008
79
0.020
 Why?
Models, Econometric
1
2008
35
0.020
 Why?
Prospective Studies
2
2012
7512
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
95
0.020
 Why?
Social Isolation
1
2007
61
0.020
 Why?
Intelligence
1
2007
127
0.020
 Why?
Puberty
1
2008
152
0.020
 Why?
Body Weight
1
2011
985
0.020
 Why?
Child Behavior Disorders
1
2007
141
0.020
 Why?
Exercise
1
2016
2064
0.010
 Why?
Insurance, Health
1
2007
287
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1083
0.010
 Why?
Genotype
1
2009
1872
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Health Status Indicators
1
2004
168
0.010
 Why?
Organizational Innovation
1
2004
139
0.010
 Why?
Case-Control Studies
1
2010
3556
0.010
 Why?
Systems Integration
1
2003
37
0.010
 Why?
Computer Systems
1
2003
45
0.010
 Why?
Motor Activity
1
2007
714
0.010
 Why?
Child Welfare
1
2004
223
0.010
 Why?
Self Disclosure
1
2002
65
0.010
 Why?
Histamine H1 Antagonists
1
2002
28
0.010
 Why?
Drug Administration Schedule
1
2004
749
0.010
 Why?
Administration, Intranasal
1
2002
89
0.010
 Why?
Confidence Intervals
1
2002
331
0.010
 Why?
Regression Analysis
1
2003
1007
0.010
 Why?
Nurse's Role
1
2003
166
0.010
 Why?
Point-of-Care Systems
1
2003
178
0.010
 Why?
Health Care Surveys
1
2002
564
0.010
 Why?
Sex Distribution
1
2001
373
0.010
 Why?
Patient Satisfaction
1
2004
671
0.010
 Why?
Linear Models
1
2002
857
0.010
 Why?
Disease Management
1
2003
615
0.010
 Why?
Decision Support Systems, Clinical
1
2003
236
0.010
 Why?
Caregivers
1
2007
903
0.010
 Why?
Bronchoscopy
1
2000
216
0.010
 Why?
Internet
1
2003
678
0.010
 Why?
Pregnancy
1
2010
6736
0.010
 Why?
Survival Analysis
1
2000
1278
0.010
 Why?
Infant, Newborn
1
2004
6051
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)